Evidence map›Paper›PMID 36160201›Full record

ArticleFrontiers in microbiology2022

Chicken IgY reduces the risk of

Franziska A Schwartz, Lars Christophersen, Kim Thomsen, Sarah Baekdal, Maria Pals Bendixen, Mette Jørgensen, Ida Kirstine Bull Rasmussen, Anne Sofie Laulund, Niels Høiby, Claus Moser

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Avian Antibodies as Potential Therapeutic Tools.Antibodies (Basel, Switzerland) · 2025
    Review
  3. Review
  4. IgYs: on her majesty's secret service.Frontiers in immunology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Franziska A SchwartzDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, København, Denmark.
Lars ChristophersenDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, København, Denmark.
Kim ThomsenDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, København, Denmark.
Sarah BaekdalDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, København, Denmark.
Maria Pals BendixenDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, København, Denmark.
Mette JørgensenDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, København, Denmark.
Ida Kirstine Bull RasmussenDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, København, Denmark.
Anne Sofie LaulundDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, København, Denmark.
Niels HøibyDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, København, Denmark.
Claus MoserDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen University Hospital, København, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Urinary tract infections (UTIs) with Aim: To evaluate if prophylactic repurposing of anti- Materials and methods: Results: Conclusion: Prophylactic sIgY significantly reduces the amount of bacteria in the bladder in a mouse model of

Indexed as

antibiotic resistancebiofilmIgYinflammationprophylaxisPseudomonas aeruginosaspinal cord injuryurinary tract infection

Identifiers

PMID36160201
PMCPMC9505517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.